New treatment method for Huntington's disease on the cards?

26 June 2011

In what could come as good news for patients suffering from Huntington's disease, scientists from the UK and USA have discovered a new method to treat the neurodegenerative disease that affects muscle coordination and leads to cognitive decline and dementia, and eventually death. In two separate studies, the researchers say their findings could potentially help slow down the development of Huntington's disease as well as Parkinson's and Alzheimer's diseases. The research is presented in the journal Current Biology.

Experts say Huntington's is an inherited disease of the central nervous system. Brain cells are progressively degenerated, leading to a person's inability to walk, talk and even think logically. Around 1 in 10 000 people suffer from this debilitating disease.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight



More Features in Pharmaceutical